{"id":30755,"date":"2022-06-14T17:29:00","date_gmt":"2022-06-14T09:29:00","guid":{"rendered":"https:\/\/flcube.com\/?p=30755"},"modified":"2025-03-27T17:32:43","modified_gmt":"2025-03-27T09:32:43","slug":"nhsa-releases-draft-proposals-for-nrdl-annual-renewal-process","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30755","title":{"rendered":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process"},"content":{"rendered":"\n

The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering the National Reimbursement Drug List (NRDL) annual renewal and adjustment process. These proposals include several documents that address various aspects of NRDL updates, including new rules for renewing contracts for drugs already included in the NRDL through price negotiations. The documents are open to public feedback until June 19, 2022.<\/p>\n\n\n\n

Key Changes to the Work Plan<\/strong> The 2022 NRDL adjustment work plan introduces several significant changes compared to the previous year’s approach:<\/p>\n\n\n\n

    \n
  1. Adjustment Scope<\/strong>: The 2022 proposal includes drugs with new generic names approved for marketing from January 1, 2017, to June 30, 2022, and drugs approved for major new indications or functional changes during the same period. This represents an expansion from the 2021 scope, which covered drugs approved from January 1, 2016, to June 30, 2021.<\/li>\n\n\n\n
  2. Non-NRDL Drugs<\/strong>: The 2022 proposal specifies four categories of non-NRDL drugs that may be considered for inclusion, compared to three categories in 2021.<\/li>\n\n\n\n
  3. Drug Removal Criteria<\/strong>: The 2022 proposal outlines specific circumstances under which drugs may be removed from the NRDL, including situations where the drug’s risk is considered greater than its benefit, the drug has been removed from the national drug procurement platform, or the drug’s price is significantly higher than comparable alternatives.<\/li>\n\n\n\n
  4. Work Procedures<\/strong>: The 2022 timeline for the adjustment process is May-August 2022 for preparation, filing, expert review, negotiation, and public results, compared to June-November 2021 in the previous year’s plan.<\/li>\n<\/ol>\n\n\n\n

    Public Feedback Period<\/strong> The NHSA has invited public feedback on the draft proposals until June 19, 2022. Stakeholders, including pharmaceutical companies, healthcare providers, and patient advocacy groups, are encouraged to submit their comments and suggestions during this period.<\/p>\n\n\n\n

    Fineline Info & Tech Analysis<\/strong> Fineline Info & Tech will produce a comprehensive report on the proposed changes to the NRDL adjustment process in the near term. This report will provide detailed analysis of the implications for pharmaceutical companies, healthcare providers, and patients.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

    <\/p>\n","protected":false},"excerpt":{"rendered":"

    The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[13,2335,31,67,14,68,24,74],"class_list":["post-30755","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-covid-19","tag-edl-drugs","tag-generic-drugs","tag-nhsa-prev-smia","tag-nmpa","tag-pediatric-drugs","tag-rare-orphan-disease-drugs","tag-rdl"],"yoast_head":"\nNHSA Releases Draft Proposals for NRDL Annual Renewal Process - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering the National Reimbursement Drug List (NRDL) annual renewal and adjustment process. These proposals include several documents that address various aspects of NRDL updates, including new rules for renewing contracts for drugs already included in the NRDL through price negotiations. The documents are open to public feedback until June 19, 2022.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30755\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NHSA Releases Draft Proposals for NRDL Annual Renewal Process\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30755\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T09:29:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T09:32:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NHSA Releases Draft Proposals for NRDL Annual Renewal Process\",\"datePublished\":\"2022-06-14T09:29:00+00:00\",\"dateModified\":\"2025-03-27T09:32:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755\"},\"wordCount\":324,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"COVID-19\",\"EDL drugs\",\"Generic drugs\",\"NHSA (prev. SMIA)\",\"NMPA\",\"Pediatric drugs\",\"Rare \\\/ orphan disease drugs\",\"RDL\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30755#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30755\",\"name\":\"NHSA Releases Draft Proposals for NRDL Annual Renewal Process - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-06-14T09:29:00+00:00\",\"dateModified\":\"2025-03-27T09:32:43+00:00\",\"description\":\"The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering the National Reimbursement Drug List (NRDL) annual renewal and adjustment process. These proposals include several documents that address various aspects of NRDL updates, including new rules for renewing contracts for drugs already included in the NRDL through price negotiations. The documents are open to public feedback until June 19, 2022.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30755\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30755#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHSA Releases Draft Proposals for NRDL Annual Renewal Process\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process - Insight, China's Pharmaceutical Industry","description":"The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering the National Reimbursement Drug List (NRDL) annual renewal and adjustment process. These proposals include several documents that address various aspects of NRDL updates, including new rules for renewing contracts for drugs already included in the NRDL through price negotiations. The documents are open to public feedback until June 19, 2022.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30755","og_locale":"en_US","og_type":"article","og_title":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=30755","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-06-14T09:29:00+00:00","article_modified_time":"2025-03-27T09:32:43+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30755#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30755"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process","datePublished":"2022-06-14T09:29:00+00:00","dateModified":"2025-03-27T09:32:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30755"},"wordCount":324,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["COVID-19","EDL drugs","Generic drugs","NHSA (prev. SMIA)","NMPA","Pediatric drugs","Rare \/ orphan disease drugs","RDL"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30755#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30755","url":"https:\/\/flcube.com\/?p=30755","name":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-06-14T09:29:00+00:00","dateModified":"2025-03-27T09:32:43+00:00","description":"The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering the National Reimbursement Drug List (NRDL) annual renewal and adjustment process. These proposals include several documents that address various aspects of NRDL updates, including new rules for renewing contracts for drugs already included in the NRDL through price negotiations. The documents are open to public feedback until June 19, 2022.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30755#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30755"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30755#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NHSA Releases Draft Proposals for NRDL Annual Renewal Process"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30755"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30755\/revisions"}],"predecessor-version":[{"id":30756,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30755\/revisions\/30756"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}